[DJ's left nut]

Originally Posted by Hammock Parties

I don't think these are "official" trials.

However...

Encouraging: French Clinical trial

36 patients treated in 3 Groups for 6 days (Graph):

1- Black: No drug
2- Blue: Hydroxycholorquine (HxC). 50% virus cleared
3- Green: HxC + Azithromycin: 100% cleared in 5days

More news from China trials next monthhttps://t.co/rCHyKuaO5Y pic.twitter.com/mqU7wPggfF

— Dlawer Ala'Aldeen (@Dlawer) March 21, 2020

I think it's fair to remain optimistic.

Don't let 'em shout you down, Clay (but maybe stop calling it a wonder-drug for another week or two...)

A clinically confirmed effective therapeutic treatment combined w/ robust testing protocols would truly flip this entire script. It would change everything, up to and including the need to seriously consider 'pre-emptive exposure' for low risk groups.

I will say the potential for this thing to change EVERYTHING and yet the continued heightened reactions from healthcare and government leaders tells me that this isn't quite the panacea it's being made out to be. If initial results were that this think yields marginally better outcomes in 25% of cases, I'd understand a slow reaction to it. But these initial results are effectively saying "yeah, this will cut capacity issues by 75% and all but eliminate mortality apart from those who are exceptionally high risk..." and yet reactions are tepid at best.

If something looks too good to be true...